IFDA-licensed importer
Marketing authorisation holder for every product listed; dossier, IRC licensing and pharmacovigilance handled in-house.
The hospital and specialty medicines Hanpars has registered in Iran, followed by the wider reference list of finished products we can source.
The first list is our own portfolio: medicines for which Hanpars holds the Iranian marketing authorisation, grouped by therapeutic area with licensed dosage forms, strengths and ATC codes.
The second is a longer reference list of finished products we can enquire about on your behalf. Names and codes are kept exactly as recorded.
Hospital and specialty medicines registered with the Iran Food and Drug Administration (IFDA) and imported by HANPARS from GMP-certified manufacturers in Türkiye, China and India. Listed by therapeutic area with WHO ATC codes, dosage forms and strengths.
Marketing authorisation holder for every product listed; dossier, IRC licensing and pharmacovigilance handled in-house.
Contracted supplier to the IFDA under the national reserve programme for naloxone, misoprostol, hydrocortisone, etomidate and contrast media.
Hospital and pharmacy coverage through Pakhsh Razi, Darougostar Tooba and Dey Darou Omid.
GMP-certified sources, batch certificates of analysis on file for every shipment, cold chain for biologics and heparin.
Dosage forms, strengths and WHO ATC codes as licensed. Status as of October 2026.
Diagnostic imaging
Iodinated and ionic contrast agents for CT, angiography and urography, supplied to imaging centres and hospitals nationwide.
Endocrine, gynaecology and oncology support
Corticosteroids, oestrogens, antiandrogen combinations and calcium-regulating hormones.
Neurology and mental health
Antidepressants, antipsychotics, anticonvulsants and antiparkinsonian agents — the fastest-growing part of the portfolio.
Antithrombotic, antiarrhythmic and diuretic therapy
Platelet inhibitors, beta-blockers and loop diuretics for chronic cardiovascular care.
Antibacterials, antituberculars and antimalarials
Injectable and oral antibiotics, first-line tuberculosis treatment and aminoquinolines.
Anaesthesia, resuscitation and respiratory
Products for emergency departments, operating theatres and ICUs, several of them supplied under the national Strategic Medicine Reserve.
Biologics and chemoprotection
Anti-TNF biologic therapy and folinate rescue.
Hepatobiliary and obstetric care
Bile-acid therapy and prostaglandin analogue for obstetric indications.
Osteoporosis
Weekly bisphosphonate therapy.
| Molecule | ATC | Dosage form and strength | Therapeutic area | Origin | Status | Enquiry |
|---|---|---|---|---|---|---|
| Alendronate (as sodium) | M05BA04 | Tablet70 mg | Bone & metabolism | China | Available in Iran | Enquire |
| Aminophylline | R03DA05 | Solution for injection25 mg/mL 10 mL | Emergency & critical care | China | Available in Iran | Enquire |
| Ampicillin | J01CA01 | Powder for injection250 mg | Anti-infectives | China | Available in Iran | Enquire |
| Ampicillin / sulbactam | J01CR01 | Powder for injection1 g/0.5 g | Anti-infectives | China | Available in Iran | Enquire |
| Atropine sulfate | A03BA01 | Solution for injection0.5 mg/mL | Emergency & critical care | China | Launching | Enquire |
| Betahistine dihydrochloride | N07CA01 | Tablet8 mg | CNS & psychiatry | Origin on request | Launching | Enquire |
| Calcitonin | H05BA03 | Solution for injection50 IU/mL | Hormones & endocrinology | China | Available in Iran | Enquire |
| Calcium folinate | V03AF03 | Powder for injection100 mg | Immunology & oncology support | China | Available in Iran | Enquire |
| Carbamazepine | N03AF01 | Extended-release Tablet400 mg | CNS & psychiatry | Origin on request | Launching | Enquire |
| Cefuroxime (as axetil) | J01DC02 | Tablet500 mg | Anti-infectives | China | Available in Iran | Enquire |
| Chloroquine phosphate | P01BA01 | Tablet250 mg | Anti-infectives | China | Available in Iran | Enquire |
| Clomipramine hydrochloride | N06AA04 | Tablet25 mg | CNS & psychiatry | China | Available in Iran | Enquire |
| Clonazepam | N03AE01 | Tablet2 mg | CNS & psychiatry | China | Launching | Enquire |
| Clopidogrel (as bisulfate) | B01AC04 | Tablet75 mg | Cardiovascular | China, Türkiye | Available in Iran | Enquire |
| Clozapine | N05AH02 | Tablet25 mg | CNS & psychiatry | China | Available in Iran | Enquire |
| Cyproterone compound | G03HB01 | Tablet2 mg/0.035 mg | Hormones & endocrinology | China | Available in Iran | Enquire |
| Epinephrine | C01CA24 | Solution for injection1 mg/mL | Emergency & critical care | China | Launching | Enquire |
| Escitalopram (as oxalate) | N06AB10 | Tablet10 mg | CNS & psychiatry | Origin on request | Launching | Enquire |
| Estradiol valerate | G03CA03 | Tablet1 mg Tablet2 mg | Hormones & endocrinology | China, India | Available in Iran | Enquire |
| Etomidate | N01AX07 | Solution for injection2 mg/mL 10 mL | Emergency & critical care | China | Available in Iran | Enquire |
| Exemestane | L02BG06 | Tablet25 mg | Hormones & endocrinology | China | Available in Iran | Enquire |
| Furosemide | C03CA01 | Tablet40 mg | Cardiovascular | Türkiye | Launching | Enquire |
| Heparin sodium | B01AB01 | Solution for injection5000 IU/mL 5 mL | Emergency & critical care | Türkiye | Available in Iran | Enquire |
| Hydrocortisone (as sodium succinate) | H02AB09 | Powder for injection100 mg | Hormones & endocrinology | China | Available in Iran | Enquire |
| Hydroxychloroquine sulfate | P01BA02 | Tablet200 mg | Anti-infectives | China | Available in Iran | Enquire |
| Hyoscine-N-butylbromide | A03BB01 | Tablet10 mg | Emergency & critical care | Origin on request | Launching | Enquire |
| Infliximab | L04AB02 | Powder for injection100 mg | Immunology & oncology support | China | Available in Iran | Enquire |
| Iodixanol | V08AB09 | Solution for injection320 mg/mL 50 mL | Contrast media | China | Available in Iran | Enquire |
| Iohexol | V08AB02 | Solution for injection300 mg/mL 50 mL Solution for injection350 mg/mL 100 mL | Contrast media | China | Available in Iran | Enquire |
| Isoniazid | J04AC01 | Tablet300 mg | Anti-infectives | India | Launching | Enquire |
| Lidocaine / chlorhexidine | N01BB52 | Gel2% / 0.05% · 12.5 g | Emergency & critical care | Türkiye | Available in Iran | Enquire |
| Meglumine compound | V08AA01 | Solution for injection66% / 10% · 20 mL | Contrast media | China | Available in Iran | Enquire |
| Misoprostol | G02AD06 | Tablet200 µg | Gastroenterology & women’s health | China | Available in Iran | Enquire |
| Naloxone hydrochloride | V03AB15 | Solution for injection0.4 mg/mL | Emergency & critical care | China | Available in Iran | Enquire |
| Olanzapine | N05AH03 | Tablet5 mg | CNS & psychiatry | China | Available in Iran | Enquire |
| Perphenazine | N05AB03 | Tablet2 mg Tablet4 mg | CNS & psychiatry | Origin on request | Launching | Enquire |
| Pregabalin | N03AX16 | Capsule150 mg Capsule75 mg | CNS & psychiatry | China | Launching | Enquire |
| Quetiapine (as fumarate) | N05AH04 | Tablet100 mg Tablet25 mg | CNS & psychiatry | Türkiye | Launching | Enquire |
| Rifampicin | J04AB02 | Capsule150 mg Capsule300 mg | Anti-infectives | China | Available in Iran | Enquire |
| Salbutamol (as sulfate) | R03AC02 | Metered-dose inhaler100 µg/dose, 200 doses | Emergency & critical care | China | Available in Iran | Enquire |
| Sertraline (as hydrochloride) | N06AB06 | Tablet100 mg Tablet50 mg | CNS & psychiatry | China, Türkiye | Available in Iran | Enquire |
| Sotalol hydrochloride | C07AA07 | Tablet80 mg | Cardiovascular | Origin on request | Launching | Enquire |
| Topiramate | N03AX11 | Tablet100 mg Tablet25 mg Tablet50 mg | CNS & psychiatry | Origin on request | Launching | Enquire |
| Trihexyphenidyl hydrochloride | N04AA01 | Tablet2 mg | CNS & psychiatry | Origin on request | Launching | Enquire |
| Ursodeoxycholic acid | A05AA02 | Capsule300 mg | Gastroenterology & women’s health | Türkiye | Launching | Enquire |
| Vancomycin (as hydrochloride) | J01XA01 | Powder for injection500 mg | Anti-infectives | China | Available in Iran | Enquire |
Try another molecule, ATC code or therapeutic area.
Portfolio status reflects IFDA licensing and import scheduling as of October 2026. Dosage forms and strengths are as licensed by the IFDA; manufacturer details and certificates are available to healthcare institutions and partners on request. Confirm current availability and launch timing when enquiring.
From Letter of Authorization to pharmacy shelf — HANPARS prepares and submits the IFDA dossier, obtains the IRC licence, manages currency allocation and import, and places the product with national distributors. We are actively expanding our Turkish and European supplier base.
| Product | Code | Enquiry |
|---|---|---|
| ACITRETIN CAPSULE ORAL 10 mg | 17 | Enquire |
| ACITRETIN CAPSULE ORAL 25 mg | 18 | Enquire |
| ACTIVATED PROTHROMBIN COMPLEX (CONCENTRATED) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU] | 19 | Enquire |
| ACICLOVIR OINTMENT OPHTHALMIC 3 % 3 g | 20 | Enquire |
| ALBUMIN (HUMAN) INJECTION, SOLUTION PARENTERAL 20 % 50 mL | 27 | Enquire |
| AMINOPHYLLINE INJECTION PARENTERAL 25 mg/1mL 10 mL | 61 | Enquire |
| AMIODARONE HYDROCHLORIDE INJECTION PARENTERAL 50 mg/1 mL 3 mL | 64 | Enquire |
| AMPHOTERICIN B INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 50 mg | 79 | Enquire |
| AMPICILLIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 250 mg | 81 | Enquire |
| ANTHOCYANOSIDE A TABLET ORAL 100 mg/5 mg | 88 | Enquire |
| ASPARAGINASE INJECTION, POWDER, FOR SOLUTION PARENTERAL 10000 [iU] | 113 | Enquire |
| ATRACURIUM BESYLATE INJECTION PARENTERAL 10 mg/1mL 2.5 mL | 116 | Enquire |
| ATRACURIUM BESYLATE INJECTION PARENTERAL 10 mg/1mL 5 mL | 117 | Enquire |
| BECLOMETHASONE DIPROPIONATE INHALANT RESPIRATORY 50 ug/1{dose} 200 {Puff} | 133 | Enquire |
| BLEOMYCIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 15 [iU] | 170 | Enquire |
| BROMHEXINE HYDROCHLORIDE INJECTION PARENTERAL 2 mg/1mL 2 mL | 176 | Enquire |
| BURN OINTMENT OINTMENT TOPICAL 30 %/50 % 30 g | 183 | Enquire |
| CALCITONIN INJECTION PARENTERAL 50 [iU]/1mL | 194 | Enquire |
| CALCIUM GLUCONATE INJECTION PARENTERAL 10 % 10 mL | 200 | Enquire |
| CARBAMAZEPINE TABLET ORAL 200 mg | 208 | Enquire |
| CARMUSTINE INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg | 219 | Enquire |
| CEFAZOLIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg | 224 | Enquire |
| CEFOTAXIME (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg | 229 | Enquire |
| CEFTIZOXIME INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g | 233 | Enquire |
| CEFTIZOXIME INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg | 234 | Enquire |
| CEFTRIAXONE (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g | 237 | Enquire |
| CEFTRIAXONE (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg | 239 | Enquire |
| CEFALEXIN POWDER, FOR SUSPENSION ORAL 250 mg/5 mL 100 mL | 246 | Enquire |
| CHLORAMBUCIL TABLET ORAL 2 mg | 262 | Enquire |
| CHLORAMPHENICOL SOLUTION, DROPS OPHTHALMIC 0.5 % 10 mL | 264 | Enquire |
| CHOLESTYRAMINE POWDER, FOR SUSPENSION ORAL 4 g | 283 | Enquire |
| CINNARIZINE TABLET ORAL 25 MG | 292 | Enquire |
| CINNARIZINE TABLET ORAL 75MG | 293 | Enquire |
| CLIDINIUM / CHLORDIAZEPOXIDE TABLET ORAL 2.5 mg/5 mg | 308 | Enquire |
| CLOXACILLIN (AS SODIUM) CAPSULE ORAL 500 mg | 331 | Enquire |
| CLOXACILLIN (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg | 332 | Enquire |
| COLCHICINE TABLET ORAL 1 mg | 348 | Enquire |
| CONJUGATED ESTROGENS TABLET ORAL 0.625 mg | 352 | Enquire |
| CONJUGATED ESTROGENS CREAM VAGINAL 0.625 mg/1g 42.5 g | 353 | Enquire |
| CONJUGATED ESTROGENS TABLET ORAL 1.25 mg | 354 | Enquire |
| CROTAMITON CREAM TOPICAL 10 % 30 g | 366 | Enquire |
| CYCLOPHOSPHAMIDE TABLET ORAL 50 mg | 369 | Enquire |
| CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg | 370 | Enquire |
| CYPROTERONE COMPOUND TABLET ORAL 2 mg/0.035 mg | 374 | Enquire |
| DANTROLENE SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 20 mg | 382 | Enquire |
| DAPSONE TABLET ORAL 100 mg | 383 | Enquire |
| DAUNORUBICIN (AS HYDROCHLORIDE) INJECTION, POWDER, FOR SOLUTION PARENTERAL 20 mg | 384 | Enquire |
| DEXTROSE / SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 5 %/0.9 % 500 mL | 393 | Enquire |
| DEXTROSE / SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 3.33 %/0.3 % 1000 mL | 395 | Enquire |
| DEXTROSE INJECTION, SOLUTION INTRAVENOUS 10 % 500 mL | 411 | Enquire |
| DIAZOXIDE CAPSULE ORAL 100 mg | 421 | Enquire |
| DIGOXIN INJECTION PARENTERAL 0.25 mg/1mL 2 mL | 438 | Enquire |
| DIMETHYL SULFOXIDE SOLUTION PARENTERAL 50 % 50 mL | 450 | Enquire |
| DOPAMINE HYDROCHLORIDE INJECTION PARENTERAL 40 mg/1mL 5 mL | 468 | Enquire |
| DOXEPIN CAPSULE ORAL 10 mg | 470 | Enquire |
| DOXEPIN CAPSULE ORAL 25 mg | 471 | Enquire |
| EPIRUBICIN HYDROCHLORIDE INJECTION, POWDER, FOR SOLUTION PARENTERAL 50 mg | 492 | Enquire |
| ERGOTAMINE TARTRATE / CAFFEINE TABLET ORAL 1 mg/100 mg | 493 | Enquire |
| ESTRADIOL VALERATE INJECTION PARENTERAL 10 mg/1mL | 502 | Enquire |
| ESTRADIOL VALERATE TABLET ORAL 1 mg | 503 | Enquire |
| ESTRADIOL VALERATE TABLET ORAL 2 mg | 504 | Enquire |
| ETHOSUXIMIDE SYRUP ORAL 250 mg/5mL 240 mL | 513 | Enquire |
| ETHOSUXIMIDE CAPSULE ORAL 250 mg | 514 | Enquire |
| ETOPOSIDE INJECTION, SOLUTION INTRAVENOUS 20 mg/1mL 5 mL | 518 | Enquire |
| ETOPOSIDE CAPSULE ORAL 50 mg | 520 | Enquire |
| FLUCYTOSINE TABLET ORAL 500 mg | 541 | Enquire |
| FLUDROCORTISONE ACETATE TABLET ORAL 0.1 mg | 543 | Enquire |
| FLUMAZENIL INJECTION PARENTERAL 0.1 mg/1mL 5 mL | 544 | Enquire |
| FLUOROMETHOLONE SUSPENSION, DROPS OPHTHALMIC 0.1 % 5 mL | 548 | Enquire |
| FUROSEMIDE TABLET ORAL 40 mg | 571 | Enquire |
| GABAPENTIN CAPSULE ORAL 100 mg | 572 | Enquire |
| GLUCAGON INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 mg | 597 | Enquire |
| GLYCINE SOLUTION IRRIGATION 1.5 % 3000 mL | 601 | Enquire |
| HALOPERIDOL (AS DECANOATE) INJECTION PARENTERAL 50 mg/1mL 1 mL | 616 | Enquire |
| HALOPERIDOL (AS LACTATE) SOLUTION ORAL 2 mg/1mL 15 mL | 618 | Enquire |
| HEPARIN SODIUM INJECTION PARENTERAL 5000 [iU]/1mL 1 mL | 624 | Enquire |
| HYDRALAZINE HYDROCHLORIDE INJECTION, POWDER, FOR SOLUTION PARENTERAL 20 mg | 632 | Enquire |
| HYDROCORTISONE (AS SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg | 637 | Enquire |
| HYDROCORTISONE TABLET ORAL 10 mg | 638 | Enquire |
| HYDROCORTISONE ENEMA RECTAL 100 mg/60mL | 641 | Enquire |
| HYDROXYUREA CAPSULE ORAL 500 mg | 648 | Enquire |
| HYDROXYZINE HYDROCHLORIDE TABLET ORAL 10 mg | 651 | Enquire |
| HYDROXYZINE HYDROCHLORIDE TABLET ORAL 25 mg | 652 | Enquire |
| PERITONEAL DIALYSIS I SOLUTION INTRAPERITONEAL 13.62 g/132 meq/3.5 meq/1.5 meq/35 meq/102 meq/1000 mL 2 L | 690 | Enquire |
| PERITONEAL DIALYSIS II SOLUTION INTRAPERITONEAL 22.7 g/1025.67 meq/3.5 meq/1.5 meq/35 meq/132 meq/1000 mL 2 L | 693 | Enquire |
| PERITONEAL DIALYSIS III SOLUTION INTRAPERITONEAL 38.6 g/5.67 g/0.257 g/0.152 g/3.922 g/1000 mL 2 L | 694 | Enquire |
| IOHEXOL INJECTION PARENTERAL 240 mg/1mL 50 mL | 699 | Enquire |
| IPRATROPIUM BROMIDE SPRAY RESPIRATORY 20 ug/1{dose} 200 {dose} | 708 | Enquire |
| ISONIAZID TABLET ORAL 300 mg | 713 | Enquire |
| KETOCONAZOLE CREAM TOPICAL 2 % 30 g | 725 | Enquire |
| KETOCONAZOLE TABLET ORAL 200 mg | 726 | Enquire |
| LAMOTRIGINE TABLET ORAL 100 mg | 732 | Enquire |
| LAMOTRIGINE TABLET ORAL 50 mg | 733 | Enquire |
| CALCIUM FOLINATE TABLET ORAL 15 mg | 738 | Enquire |
| LEVAMISOLE TABLET ORAL 50 mg | 741 | Enquire |
| LIDOCAINE HYDROCHLORIDE GEL TOPICAL 2 % 15 g | 756 | Enquire |
| MANNITOL INJECTION, SOLUTION INTRAVENOUS 20 % 500 mL | 782 | Enquire |
| MAPROTILINE HYDROCHLORIDE TABLET ORAL 25 mg | 783 | Enquire |
| MAPROTILINE HYDROCHLORIDE TABLET ORAL 75 mg | 784 | Enquire |
| MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION PARENTERAL 150 mg/1mL 1 mL | 791 | Enquire |
| MAFENIDE ACETATE CREAM TOPICAL 112 mg/1g 30 g | 795 | Enquire |
| MEGLUMINE COMPOUND INJECTION PARENTERAL 66 %/10 % 100 mL | 798 | Enquire |
| MEGLUMINE COMPOUND INJECTION PARENTERAL 66 %/10 % 20 mL | 799 | Enquire |
| MELPHALAN TABLET ORAL 2 mg | 803 | Enquire |
| MERCAPTOPURINE TABLET ORAL 50 mg | 811 | Enquire |
| MESALAZINE TABLET, DELAYED RELEASE ORAL 500 mg | 813 | Enquire |
| MESNA INJECTION PARENTERAL 100 mg/1mL 4 mL | 814 | Enquire |
| METHADONE HYDROCHLORIDE INJECTION PARENTERAL 5 mg/1mL 1 mL | 819 | Enquire |
| METHYLERGONOVINE MALEATE TABLET ORAL 0.125 mg | 833 | Enquire |
| METHYLTESTOSTERONE TABLET ORAL 25 mg | 838 | Enquire |
| METRONIDAZOLE INJECTION, SOLUTION PARENTERAL 5 mg/1mL 100 mL | 843 | Enquire |
| MINOXIDIL TABLET ORAL 10 mg | 855 | Enquire |
| MITOMYCIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 2 mg | 857 | Enquire |
| MITOTANE TABLET ORAL 500 mg | 858 | Enquire |
| NANDROLONE DECANOATE INJECTION PARENTERAL 25 mg/1mL | 884 | Enquire |
| NAPHAZOLINE / ANTAZOLINE SOLUTION, DROPS OPHTHALMIC 0.05 %/0.5 % 10 mL | 888 | Enquire |
| NIFEDIPINE CAPSULE, LIQUID FILLED ORAL 10 mg | 902 | Enquire |
| NIFEDIPINE TABLET ORAL 10 mg | 903 | Enquire |
| NIMODIPINE INJECTION, SOLUTION INTRAVENOUS 0.2 mg/1mL 50 mL | 904 | Enquire |
| NITROFURANTOIN TABLET ORAL 100 mg | 907 | Enquire |
| NITROGLYCERIN OINTMENT TOPICAL 2 % 30 g | 910 | Enquire |
| NITROPRUSSIDE SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 50 mg | 916 | Enquire |
| NORTRIPTYLINE (AS HYDROCHLORIDE) TABLET ORAL 10 mg | 921 | Enquire |
| NORTRIPTYLINE (AS HYDROCHLORIDE) TABLET ORAL 25 mg | 922 | Enquire |
| OXYBUTYNIN HYDROCHLORIDE TABLET ORAL 5 mg | 935 | Enquire |
| OXYTOCIN INJECTION PARENTERAL 10 [iU]/1mL | 939 | Enquire |
| POTASSIUM CHLORIDE CONCENTRATED INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 2 meq/1mL 50 mL | 941 | Enquire |
| PATENT BLUE V INJECTION PARENTERAL 25 mg/1mL 2 mL | 955 | Enquire |
| PERPHENAZINE TABLET ORAL 2 mg | 972 | Enquire |
| PERPHENAZINE TABLET ORAL 4 mg | 973 | Enquire |
| PERPHENAZINE TABLET ORAL 8 mg | 975 | Enquire |
| PHENOBARBITAL SODIUM INJECTION PARENTERAL 200 mg/1mL | 977 | Enquire |
| PHENOXYBENZAMINE CAPSULE ORAL 10 mg | 984 | Enquire |
| PHENYLEPHRINE HYDROCHLORIDE SOLUTION, DROPS NASAL 0.25 % 10 mL | 988 | Enquire |
| PHENYLEPHRINE HYDROCHLORIDE SOLUTION, DROPS OPHTHALMIC 5 % 10 mL | 991 | Enquire |
| PHENYTOIN SODIUM INJECTION PARENTERAL 50 mg/1mL 5 mL | 995 | Enquire |
| VITAMIN K1 (PHYTOMENADIONE) INJECTION PARENTERAL 10 mg/1mL 1 mL | 1003 | Enquire |
| VITAMIN K1 (PHYTOMENADIONE) INJECTION PARENTERAL 2 mg/1mL 0.5 mL | 1004 | Enquire |
| VITAMIN K1 (PHYTOMENADIONE) TABLET ORAL 10 mg | 1005 | Enquire |
| PIMOZIDE TABLET ORAL 4 mg | 1009 | Enquire |
| POTASSIUM AMINOBENZOIC ACID (POTABA) TABLET ORAL 500 mg | 1026 | Enquire |
| PREDNISOLONE TABLET ORAL 50 mg | 1044 | Enquire |
| PREDNISOLONE TABLET ORAL 5 mg | 1045 | Enquire |
| PROCAINAMIDE HYDROCHLORIDE INJECTION PARENTERAL 100 mg/1mL 10 mL | 1054 | Enquire |
| PROPYLTHIOURACIL TABLET ORAL 50 mg | 1072 | Enquire |
| PYRIDOSTIGMINE BROMIDE TABLET ORAL 60 mg | 1080 | Enquire |
| QUINIDINE SULFATE TABLET ORAL 200 mg | 1088 | Enquire |
| ANTI-D IMMUNOGLOBULIN INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION INTRAMUSCULAR 300 ug | 1099 | Enquire |
| RIFAMPICIN CAPSULE ORAL 150 mg | 1101 | Enquire |
| RIFAMPICIN CAPSULE ORAL 300 mg | 1103 | Enquire |
| RINGER LACTATE INJECTION, SOLUTION INTRAVENOUS 130 meq/3 meq/4 meq/109 meq/28 meq/1L 500 mL | 1107 | Enquire |
| SALBUTAMOL (AS SULFATE) TABLET ORAL 2 mg | 1114 | Enquire |
| SELEGILINE HYDROCHLORIDE TABLET ORAL 5 mg | 1121 | Enquire |
| SILVER SULFADIAZINE CREAM TOPICAL 1 % 50 g | 1130 | Enquire |
| SODIUM TETRADECYL SULFATE INJECTION PARENTERAL 1 % 2 mL | 1136 | Enquire |
| SODIUM TETRADECYL SULFATE INJECTION PARENTERAL 3 % 2 mL | 1137 | Enquire |
| SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.9 % 1000 mL | 1141 | Enquire |
| SODIUM CHLORIDE SOLUTION IRRIGATION 0.9 % 1000 mL | 1142 | Enquire |
| SODIUM CHLORIDE SOLUTION IRRIGATION 0.9 % 3 L | 1143 | Enquire |
| SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.9 % 500 mL | 1144 | Enquire |
| Sodium Chloride Injection, Solution Parentral 0.9% 500 ml | 1144 | Enquire |
| SODIUM CHLORIDE SOLUTION, DROPS OPHTHALMIC 5 % 10 mL | 1147 | Enquire |
| SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 5 % 50 mL | 1148 | Enquire |
| SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.45 % 1000 mL | 1149 | Enquire |
| Sodium Thiosulfate Injection 12.5g/ 50 ml Vial USP 25% | 1158 | Enquire |
| SOTALOL HYDROCHLORIDE TABLET ORAL 80 mg | 1164 | Enquire |
| SPECTINOMYCIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 2 g | 1166 | Enquire |
| SPIRAMYCIN TABLET ORAL 500 mg | 1168 | Enquire |
| SULFACETAMIDE SODIUM SOLUTION, DROPS OPHTHALMIC 10 % 10 mL | 1180 | Enquire |
| SULFACETAMIDE SODIUM SOLUTION, DROPS OPHTHALMIC 20 % 10 mL | 1181 | Enquire |
| SULFADIAZINE TABLET ORAL 500 mg | 1183 | Enquire |
| TESTOSTERONE ENANTHATE INJECTION PARENTERAL 100 mg/1mL | 1201 | Enquire |
| TETANUS IMMUNE GLOBULIN INJECTION PARENTERAL 250 [iU]/1mL | 1202 | Enquire |
| TETRACAINE HYDROCHLORIDE SOLUTION, DROPS OPHTHALMIC 0.5 % 10 mL | 1204 | Enquire |
| TETRACYCLINE HYDROCHLORIDE OINTMENT OPHTHALMIC 1 % 3 g | 1206 | Enquire |
| TETRACYCLINE HYDROCHLORIDE CAPSULE ORAL 250 mg | 1207 | Enquire |
| THIOGUANINE TABLET ORAL 40 mg | 1217 | Enquire |
| THIORIDAZINE HYDROCHLORIDE TABLET ORAL 10 mg | 1220 | Enquire |
| THIORIDAZINE HYDROCHLORIDE TABLET ORAL 100 mg | 1221 | Enquire |
| THIORIDAZINE HYDROCHLORIDE TABLET ORAL 25 mg | 1222 | Enquire |
| TICLOPIDINE HYDROCHLORIDE TABLET ORAL 250 mg | 1225 | Enquire |
| TRANYLCYPROMINE TABLET ORAL 10 mg | 1241 | Enquire |
| TRETINOIN CREAM TOPICAL 0.05 % 15 g | 1245 | Enquire |
| TRIFLUOPERAZINE INJECTION INTRAMUSCULAR 1 mg/1mL | 1254 | Enquire |
| VANCOMYCIN (AS HYDROCHLORIDE) INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg | 1276 | Enquire |
| VERAPAMIL HYDROCHLORIDE INJECTION PARENTERAL 2.5 mg/1mL 2 mL | 1280 | Enquire |
| VIGABATRIN TABLET ORAL 500 mg | 1282 | Enquire |
| VINCRISTINE SULFATE INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 mg | 1284 | Enquire |
| ZINC OXIDE OINTMENT TOPICAL 25 % 30 g | 1316 | Enquire |
| METHYLPHENIDATE HYDROCHLORIDE TABLET ORAL 10 mg | 1328 | Enquire |
| CEFOTAXIME (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g | 1336 | Enquire |
| NALOXONE HYDROCHLORIDE INJECTION PARENTERAL 0.4 mg/1mL | 1341 | Enquire |
| FENTANYL (AS CITRATE) INJECTION PARENTERAL 50 ug/1mL 10 mL | 1359 | Enquire |
| YOHIMBINE HYDROCHLORIDE TABLET ORAL 2 mg | 1373 | Enquire |
| AMYL NITRITE INHALANT RESPIRATORY 0.3 mL 0.3 mL | 1388 | Enquire |
| CARBAMAZEPINE TABLET, EXTENDED RELEASE ORAL 400 mg | 1420 | Enquire |
| CHARCOAL ACTIVATED TABLET ORAL 250 mg | 1425 | Enquire |
| CICLOSPORIN INJECTION, SOLUTION INTRAVENOUS 50 mg/1mL 1 mL | 1452 | Enquire |
| DIAZOXIDE CAPSULE ORAL 50 mg | 1463 | Enquire |
| EPINEPHRINE INJECTION PARENTERAL 1 mg/1mL 1 mL | 1489 | Enquire |
| ETOMIDATE INJECTION PARENTERAL 2 mg/1mL 10 mL | 1501 | Enquire |
| ISOPROTERENOL HYDROCHLORIDE INJECTION PARENTERAL 0.2 mg/1mL | 1558 | Enquire |
| NOREPINEPHRINE (AS BITARTRATE) INJECTION, SOLUTION, CONCENTRATE PARENTERAL 1 mg/1mL 10 mL | 1620 | Enquire |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION PARENTERAL 10 mg/1mL 1 mL | 1635 | Enquire |
| PRIMIDONE SUSPENSION ORAL 125 mg/5mL 250 mL | 1650 | Enquire |
| PROTAMINE SULFATE INJECTION PARENTERAL 10 MG/1ML 5 ML | 1655 | Enquire |
| SODIUM NITRITE INJECTION PARENTERAL 30 mg/1mL | 1679 | Enquire |
| NITROGLYCERIN CAPSULE, LIQUID FILLED ORAL 0.4 mg | 1727 | Enquire |
| CLOPIDOGREL (AS BISULFATE) TABLET ORAL 75 mg | 1788 | Enquire |
| VITAMIN D3 INJECTION PARENTERAL 300000 [iU]/1mL | 1814 | Enquire |
| ADENOSINE INJECTION PARENTERAL 3 mg/1mL 2 mL | 1836 | Enquire |
| OXANDROLONE TABLET ORAL 2.5 mg | 1878 | Enquire |
| TOPIRAMATE 25 MG TABLET | 1885 | Enquire |
| PAMIDRONATE DISODIUM INJECTION, SOLUTION, CONCENTRATE PARENTERAL 9 mg/1mL 10 mL | 1899 | Enquire |
| HYDROXYPROGESTERONE CAPROATE INJECTION PARENTERAL 250 mg/1mL 1 mL | 1917 | Enquire |
| RILUZOLE TABLET ORAL 50 mg | 1921 | Enquire |
| SODIUM BENZOATE INJECTION PARENTERAL 200 mg/1mL 10 mL | 1934 | Enquire |
| ISOFLURANE INHALANT RESPIRATORY 100 % 100 mL | 1943 | Enquire |
| CLINDAMYCIN (AS PHOSPHATE) INJECTION PARENTERAL 150 mg/1mL 2 mL | 1947 | Enquire |
| FENTANYL PATCH TRANSDERMAL 25 ug/1h | 1987 | Enquire |
| FENTANYL PATCH TRANSDERMAL 50 ug/1h | 1988 | Enquire |
| LAMOTRIGINE TABLET ORAL 25 mg | 1991 | Enquire |
| CEFUROXIME (AS AXETIL) TABLET ORAL 250 mg | 2031 | Enquire |
| CEFUROXIME (AS AXETIL) TABLET ORAL 500 mg | 2032 | Enquire |
| FLUTICASONE PROPIONATE INHALANT RESPIRATORY 50 ug/1{dose} 120 {Puff} | 2053 | Enquire |
| IOHEXOL INJECTION PARENTERAL 300 mg/1mL 50 mL | 2059 | Enquire |
| IOHEXOL INJECTION PARENTERAL 300 mg/1mL 100 mL | 2060 | Enquire |
| IOHEXOL INJECTION PARENTERAL 350 mg/1mL 50 mL | 2062 | Enquire |
| IOHEXOL INJECTION PARENTERAL 350 mg/1mL 100 mL | 2063 | Enquire |
| TACROLIMUS INJECTION, SOLUTION, CONCENTRATE PARENTERAL 5 mg/1mL | 2087 | Enquire |
| CARBAMAZEPINE TABLET, EXTENDED RELEASE ORAL 200 mg | 2114 | Enquire |
| METHOTREXATE SODIUM INJECTION PARENTERAL 25 mg/1mL 2 mL | 2158 | Enquire |
| SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.45 % 500 mL | 2186 | Enquire |
| CIPROFLOXACIN (AS LACTATE) INJECTION, SOLUTION INTRAVENOUS 10 mg/1mL 20 mL | 2250 | Enquire |
| PANTOPRAZOLE (AS SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 40 mg | 2336 | Enquire |
| ACETYLCYSTEINE TABLET, EFFERVESCENT ORAL 600 mg | 2369 | Enquire |
| LEVODOPA / CARBIDOPA TABLET, EXTENDED RELEASE ORAL 100 mg/25 mg | 2383 | Enquire |
| OCTREOTIDE (AS ACETATE) INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE PARENTERAL 20 mg | 2391 | Enquire |
| SODIUM ACID PHOSPHATE (PHOSPHATE SODIUM) TABLET, EFFERVESCENT ORAL 500 mg | 2397 | Enquire |
| CEFEPIME (AS HYDROCHLORIDE) INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g | 2416 | Enquire |
| MEGESTROL ACETATE SUSPENSION ORAL 40 mg/1mL 240 mL | 2442 | Enquire |
| DIMERCAPROL INJECTION INTRAMUSCULAR 100 mg/1mL 2 mL | 2506 | Enquire |
| IODIXANOL INJECTION PARENTERAL 320 mg/1mL 50 mL | 2517 | Enquire |
| FLUTICASONE PROPIONATE INHALANT RESPIRATORY 250 ug/1{dose} 120 {Puff} | 2710 | Enquire |
| FLUTICASONE PROPIONATE INHALANT RESPIRATORY 125 ug/1{dose} 120 {Puff} | 2711 | Enquire |
| EXEMESTANE TABLET ORAL 25 mg | 2962 | Enquire |
| MEROPENEM INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg | 3283 | Enquire |
| ZONISAMIDE CAPSULE ORAL 100 mg | 3545 | Enquire |
| MAGNESIUM SULFATE INJECTION PARENTERAL 50 % 10 mL | 3823 | Enquire |
| PIPERACILLIN (AS SODIUM) / TAZOBACTAM (AS SODIUM) INJECTION, POWDER, FOR SOLUTION PARENTERAL 4 g/0.5 g | 3894 | Enquire |
| SIROLIMUS TABLET ORAL 1 mg | 4022 | Enquire |
| BECLOMETHASONE DIPROPIONATE INHALANT RESPIRATORY 250 ug/1{dose} 200 {Puff} | 4684 | Enquire |
| IODIXANOL INJECTION PARENTERAL 270 mg/1mL 50 mL | 4757 | Enquire |
| IMATINIB (AS MESYLATE) TABLET ORAL 100 mg | 4840 | Enquire |
| Dextrose /Sodium Chloride Injection, Solution Parentral 3.33% 0.3% 500ml | 4907 | Enquire |
| GALANTAMINE (AS HYDROBROMIDE) TABLET ORAL 4 mg | 4954 | Enquire |
| GALANTAMINE (AS HYDROBROMIDE) TABLET ORAL 8 mg | 4955 | Enquire |
| VALSARTAN TABLET ORAL 80 mg | 5423 | Enquire |
| OCTREOTIDE (AS ACETATE) INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE PARENTERAL 30 mg | 5427 | Enquire |
| OSELTAMIVIR (AS PHOSPHATE) CAPSULE ORAL 75 mg | 5437 | Enquire |
| MEROPENEM INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g | 5629 | Enquire |
| INFLIXIMAB INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg | 5831 | Enquire |
| IMMUNE GLOBULIN INJECTION INTRAVENOUS 50 mg/1mL 100 mL | 5842 | Enquire |
| METHYLENE BLUE INJECTION PARENTERAL 10 mg/1mL 5 mL | 5979 | Enquire |
| PRALIDOXIME (AS METHYLSULFATE) INJECTION, POWDER, FOR SOLUTION PARENTERAL 200 mg | 6323 | Enquire |
| SODIUM PHENYLBUTYRATE INJECTION PARENTERAL 200 mg/1mL 10 mL | 6369 | Enquire |
| SODIUM PHENYLBUTYRATE TABLET ORAL 500 mg | 6403 | Enquire |
| RABEPRAZOLE SODIUM TABLET, DELAYED RELEASE ORAL 20 mg | 6438 | Enquire |
| CILOSTAZOL TABLET ORAL 100 mg | 6453 | Enquire |
| TOPOTECAN (AS HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 4 mg | 6507 | Enquire |
| MODAFINIL TABLET ORAL 100 mg | 6579 | Enquire |
| BICALUTAMIDE TABLET ORAL 50 mg | 6765 | Enquire |
| LOTEPREDNOL ETABONATE SUSPENSION, DROPS OPHTHALMIC 0.5 % 5 mL | 6854 | Enquire |
| VERTEPORFIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 15 mg | 6859 | Enquire |
| ALBUMIN (HUMAN) INJECTION, SOLUTION PARENTERAL 20 % 100 mL | 6888 | Enquire |
| AMPICILLIN / SULBACTAM INJECTION, POWDER, FOR SOLUTION PARENTERAL 2 g/1 g | 6938 | Enquire |
| AMPICILLIN / SULBACTAM INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g/0.5 g | 6939 | Enquire |
| BALANCED SALT SOLUTION (2) SOLUTION OPHTHALMIC 0.64 mg/0.075 mg/0.03 mg/0.048 mg/0.17 mg/0.39 mg/1mL 500 mL | 6968 | Enquire |
| OXALIPLATIN INJECTION, SOLUTION, CONCENTRATE PARENTERAL 5 mg/1mL 10 mL | 7041 | Enquire |
| HEMODIALYSIS CONCENTRATED II ACIDIC SOLUTION, CONCENTRATE HEMODIALYSIS 3710 meq/70 meq/35 meq/87.5 meq/70 g/122.5 meq/3902.5 meq/1L 4920 mL | 7196 | Enquire |
| HEMODIALYSIS CONCENTRATED II SOLUTION, CONCENTRATE INTRAVENOUS 4725 meq/35 meq/70 meq/87.5 meq/3692.5 meq/1225 meq/70 g/1000 mL 4920 mL | 7198 | Enquire |
| ADAPALENE GEL TOPICAL 0.1 % 30 g | 7436 | Enquire |
| EPTIFIBATIDE INJECTION, SOLUTION PARENTERAL 0.75 mg/1mL 100 mL | 7469 | Enquire |
| EPTIFIBATIDE INJECTION, SOLUTION PARENTERAL 2 mg/1mL 10 mL | 7470 | Enquire |
| OMALIZUMAB INJECTION, POWDER, FOR SOLUTION PARENTERAL 150 mg | 7525 | Enquire |
| POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE ORAL 600 mg | 7564 | Enquire |
| AZITHROMYCIN POWDER, FOR SUSPENSION ORAL 200 mg/5mL 22.5 mL | 7986 | Enquire |
| MISOPROSTOL TABLET ORAL 200 ug | 8095 | Enquire |
| RISPERIDONE INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE PARENTERAL 25 mg | 8127 | Enquire |
| VALPROATE SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 400 mg | 8396 | Enquire |
| DISULFIRAM TABLET ORAL 250 mg | 8634 | Enquire |
| METOLAZONE TABLET ORAL 5 mg | 8667 | Enquire |
| EPHEDRINE HYDROCHLORIDE TABLET ORAL 30 mg | 8699 | Enquire |
| DEFERASIROX TABLET, FOR SUSPENSION ORAL 500 mg | 8997 | Enquire |
| PEGASPARGASE INJECTION, POWDER, FOR SOLUTION PARENTERAL 3750 [iU] | 9037 | Enquire |
| PEGASPARGASE INJECTION, POWDER, FOR SOLUTION PARENTERAL 3750 [iU] | 9037 | Enquire |
| CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g | 9391 | Enquire |
| CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION PARENTERAL 1000 mg | 9391 | Enquire |
| METHOTREXATE SODIUM INJECTION PARENTERAL 2.5 mg/1mL 2 mL | 9431 | Enquire |
| FACTOR VIII / VON WILLEBRAND FACTOR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU]/1200 [iU] | 9563 | Enquire |
| CALCIUM FOLINATE INJECTION PARENTERAL 10 mg/1mL 20 mL | 9572 | Enquire |
| DESMOPRESSIN (AS ACETATE) TABLET SUBLINGUAL 60 ug | 9606 | Enquire |
| MESALAZINE TABLET, DELAYED RELEASE ORAL 800 mg | 9916 | Enquire |
| IOPAMIDOL INJECTION PARENTERAL 370 mg/1mL 50 mL | 9940 | Enquire |
| EPINEPHRINE INJECTION PARENTERAL 0.1 mg/1mL 10 mL | 10484 | Enquire |
| COLISTIMETHATE SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 1000000 [iU] | 10730 | Enquire |
| CIPROFLOXACIN (AS LACTATE) INJECTION, SOLUTION INTRAVENOUS 2 mg/1mL 100 mL | 10757 | Enquire |
| HYDROXYPROGESTERONE CAPROATE INJECTION PARENTERAL 250 mg/1mL 2 mL | 11441 | Enquire |
| KETOROLAC TROMETAMOL SOLUTION, DROPS OPHTHALMIC 0.5 % 5 mL | 11458 | Enquire |
| DIGOXIN SPECIFIC ANTIBODY INJECTION PARENTERAL 40 mg | 11506 | Enquire |
| MYCOPHENOLIC ACID TABLET, DELAYED RELEASE ORAL 360 mg | 11607 | Enquire |
| NITROFURANTOIN SUSPENSION ORAL 25 mg/5mL 240 mL | 11725 | Enquire |
| SUCCINYLCHOLINE CHLORIDE INJECTION PARENTERAL 50 mg/1mL 10 mL | 11866 | Enquire |
| CISPLATIN INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 1 mg/1mL 10 mL | 11867 | Enquire |
| LEVODOPA / CARBIDOPA / ENTACAPONE TABLET ORAL 150 mg/37.5 mg/200 mg | 12112 | Enquire |
| PANCREATIN CAPSULE, DELAYED RELEASE PELLETS ORAL 25000 [iU] | 12312 | Enquire |
| EDROPHONIUM CHLORIDE INJECTION PARENTERAL 10 mg/1mL 1 mL | 12322 | Enquire |
| LEVODOPA/CARBDOPA/ENTACAPONE TABLET ORAL 50MG/12.5MG/200MG | 12482 | Enquire |
| NAGLAZYME 1 mg/ml | 12550 | Enquire |
| GALSULFASE INJECTION PARENTERAL 1 mg/1mL 5 mL | 12550 | Enquire |
| INSULIN DETEMIR INJECTION, SOLUTION PARENTERAL 100 [iU]/1mL 3 mL | 12837 | Enquire |
| CIPROFLOXACIN / DEXAMETHASONE SUSPENSION, DROPS AURICULAR (OTIC) 0.3 %/0.1 % | 12972 | Enquire |
| DABIGATRAN ETEXILATE (AS MESYLATE) CAPSULE ORAL 75 mg | 13584 | Enquire |
| PACLITAXEL (ALBUMIN BAND) NANO INJECTION, POWDER, FOR SUSPENSION PARENTERAL 100 mg | 13879 | Enquire |
| RIFAXIMIN TABLET ORAL 200 mg | 13992 | Enquire |
| TRACE METAL COMBINATION (2-1) INJECTION PARENTERAL 5.33 ug/0.34 mg/0.54 mg/99 ug/16.6 ug/0.21 mg/4.85 ug/6.9 ug/1.36 mg/1mL 10 mL | 14113 | Enquire |
| FLUOROURACIL INJECTION PARENTERAL 50 mg/1mL 20 mL | 14530 | Enquire |
| FACTOR XIII INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 250 [iU] | 14664 | Enquire |
| MIDODRINE HYDROCHLORIDE TABLET ORAL 5 mg | 15449 | Enquire |
| DEXTROSE INJECTION, SOLUTION INTRAVENOUS 20 % 50 mL | 15951 | Enquire |
| DEXTROSE INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 50 % 50 mL | 15952 | Enquire |
| DOXORUBICIN HYDROCHLORIDE INJECTION, SOLUTION, CONCENTRATE PARENTERAL 2 mg/1mL 25 mL | 15971 | Enquire |
| LEVOFLOXACIN INJECTION, SOLUTION INTRAVENOUS 5 mg/1mL 100 mL | 16320 | Enquire |
| BUDESONIDE / FORMOTEROL FUMARATE POWDER, METERED RESPIRATORY 320 ug/9 ug/1{dose} 60 {dose} | 16503 | Enquire |
| HYDROCHLOROTHIAZIDE TABLET ORAL 25 mg | 16582 | Enquire |
| CALCIUM FOLINATE INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg | 16766 | Enquire |
| TOBRAMYCIN SOLUTION RESPIRATORY 75 mg/1mL 4 mL | 16775 | Enquire |
| FERRIC CARBOXYMALTOSE INJECTION PARENTERAL 50 mg/1mL 10 mL | 16954 | Enquire |
| IVABRADINE (AS HYDROCHLORIDE) TABLET ORAL 5 mg | 17011 | Enquire |
| ROMIPLOSTIM INJECTION, POWDER, FOR SOLUTION PARENTERAL 250 ug | 17038 | Enquire |
| ROCURONIUM BROMIDE INJECTION, SOLUTION PARENTERAL 10 mg/1mL 5 mL | 17084 | Enquire |
| AMPHOTERICIN B LIPOSOME INJECTION, POWDER, FOR SOLUTION PARENTERAL 50 mg | 17094 | Enquire |
| IPRATROPIUM BROMIDE / FENOTEROL HYDROBROMIDE AEROSOL, METERED RESPIRATORY 20 ug/50 ug/1{dose} 200 {dose} | 17611 | Enquire |
| SODIUM BICARBONATE INJECTION PARENTERAL 7.5 % 50 mL | 17833 | Enquire |
| SALMETEROL (AS XINAFOATE) / FLUTICASONE PROPIONATE DISC RESPIRATORY 50 ug/500 ug/1{dose} 60 {dose} | 18046 | Enquire |
| HEPATITIS B IMMUNE GLOBULIN INJECTION PARENTERAL 50 [iU]/1mL 50 mL | 18065 | Enquire |
| LEVODOPA / CARBIDOPA / ENTACAPONE TABLET ORAL 100 mg/25 mg/200 mg | 19232 | Enquire |
| RISPERIDONE INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE PARENTERAL 37.5 mg | 19736 | Enquire |
| QUETIAPINE (AS FUMARATE) TABLET, EXTENDED RELEASE ORAL 200 mg | 19983 | Enquire |
| EVEROLIMUS TABLET ORAL 0.25 mg | 20048 | Enquire |
| AMINO ACID 10% (1) INJECTION, SOLUTION INTRAVENOUS 5 g/7.4 g/9.31 g/4.3 g/5.1 g/4.4 g/2 g/6.2 g/12 g/3 g/14 g/11 g/11.2 g/6.5 g/0.4 g/1 g/1000mL 500 mL | 20081 | Enquire |
| SALMETEROL (AS XINAFOATE) / FLUTICASONE PROPIONATE DISC RESPIRATORY 50 ug/250 ug/1{dose} 60 {dose} | 20184 | Enquire |
| SALMETEROL (AS XINAFOATE) / FLUTICASONE PROPIONATE DISC RESPIRATORY 50 ug/100 ug/1{dose} 60 {dose} | 20185 | Enquire |
| OXYCODONE HYDROCHLORIDE TABLET, EXTENDED RELEASE ORAL 20 mg | 20629 | Enquire |
| TIGECYCLINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 50 mg | 23169 | Enquire |
| ELOSULFASE ALFA INJECTION, SOLUTION, CONCENTRATE PARENTERAL 1 mg/1mL 5 mL | 25308 | Enquire |
| COLISTIMETHATE SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 4500000 [iU] | 50030 | Enquire |
| NOREPINEPHRINE (AS BITARTRATE) INJECTION, SOLUTION, CONCENTRATE PARENTERAL 1 mg/1mL 4 mL | 50047 | Enquire |
| TOBRAMYCIN / DEXAMETHASONE SUSPENSION, DROPS OPHTHALMIC 0.3 %/0.1 % 5 mL | 50056 | Enquire |
| DIMERCAPROL INJECTION PARENTERAL 50 mg/1mL 2 mL | 50079 | Enquire |
| GOSERELIN (AS ACETATE) IMPLANT PARENTERAL 3.6 mg | 50096 | Enquire |
| EPHEDRINE HYDROCHLORIDE INJECTION PARENTERAL 50 mg/1mL 1 mL | 50280 | Enquire |
| PROMETHAZINE HYDROCHLORIDE INJECTION PARENTERAL 25 mg/1mL 2 mL | 50433 | Enquire |
| CYTARABINE INJECTION, SOLUTION PARENTERAL 50 mg/1mL 20 mL | 50464 | Enquire |
| MYCOPHENOLATE MOFETIL POWDER, FOR SUSPENSION ORAL 1 g/5mL 110 g | 50710 | Enquire |
| BRENTUXIMAB VEDOTIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 50 mg | 50841 | Enquire |
| TESTOSTERONE ENANTHATE INJECTION PARENTERAL 250 mg/1mL | 50872 | Enquire |
| NIVOLUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 10 mg/1mL 10 mL | 50884 | Enquire |
| IMMUNE GLOBULIN INJECTION INTRAVENOUS 50 mg/1mL 200 mL | 50893 | Enquire |
| RISPERIDONE INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE PARENTERAL 50 mg | 50996 | Enquire |
| EPINEPHRINE AUTOINJECTOR 0.3MG | 51121 | Enquire |
| POLYMYXIN B / NEOMYCIN SULFATE / HYDROCORTISONE SUSPENSION, DROPS AURICULAR (OTIC) 10000 [iU]/5 mg/10 mg/1mL 5 mL | 51129 | Enquire |
| CHARCOAL ACTIVATED SUSPENSION ORAL 200 mg/1mL 250 mL | 51252 | Enquire |
| MEGLUMINE COMPOUND SOLUTION ORAL 66 %/10 % 120 mL | 51516 | Enquire |
| TOBRAMYCIN SOLUTION RESPIRATORY 60 mg/1mL 5 mL | 51698 | Enquire |
| LIDOCAINE / PRILOCAINE CREAM TOPICAL 2.5 %/2.5 % 15 g | 51869 | Enquire |
| NITROFURANTOIN SUSPENSION ORAL 25 mg/5mL 100 mL | 51882 | Enquire |
| HYDROXOCOBALAMIN INJECTION PARENTERAL 5 mg/1mL 2 mL | 51899 | Enquire |
| ACETYLCYSTEINE INJECTION PARENTERAL 200 mg/1mL 10 mL | 51914 | Enquire |
| DEXAMETHASONE TABLET ORAL 4 mg | 51923 | Enquire |
| LEVODOPA/CARBDOPA/ENTACAPONE TABLET ORAL 200MG/50MG/200MG | 51962 | Enquire |
| APOMORPHINE HYDROCHLORIDE INJECTION PARENTERAL 5 mg/1mL 20 mL | 51973 | Enquire |
| PIRACETAM SOLUTION ORAL 20 % 200 mL | 51981 | Enquire |
| CLINDAMYCIN PHOSPHATE / TRETINOIN GEL TOPICAL 1.2 %/0.025 % 30 g | 51995 | Enquire |
| SUCCINYLCHOLINE CHLORIDE INJECTION PARENTERAL 20 mg/1mL 5 mL | 52003 | Enquire |
| TROPICAMIDE SOLUTION, DROPS OPHTHALMIC 0.5 % 0.5 mL | 52008 | Enquire |
| MIRTAZAPINE TABLET ORAL 15 mg | 52052 | Enquire |
| HEPATITIS B IMMUNE GLOBULIN INJECTION PARENTERAL 180 [iU]/1mL 1 mL | 52059 | Enquire |
| HEPATITIS B IMMUNE GLOBULIN INJECTION PARENTERAL 334 [iU]/1mL 3 mL | 52061 | Enquire |
| ROCURONIUM BROMIDE INJECTION, SOLUTION PARENTERAL 10 mg/1mL 10 mL | 52073 | Enquire |
| PIPERAZINE SYRUP ORAL 750 mg/5 mL 60 mL | 52145 | Enquire |
| MESALAZINE ENEMA RECTAL 1 g/100mL | 52146 | Enquire |
| TESTOSTERONE GEL TOPICAL 1 % 5 g | 52157 | Enquire |
| VENETOCLAX TABLET ORAL 100 mg | 52186 | Enquire |
| VALPROATE SODIUM INJECTION PARENTERAL 100 mg/1mL 4 mL | 52223 | Enquire |
| SODIUM THIOSULFATE INJECTION PARENTERAL 250 mg/1mL 100 mL | 52259 | Enquire |
| NATRIUMTHIOSULFAT 100 ML 25% | 52259 | Enquire |
| IODIXANOL INJECTION PARENTERAL 320 mg/1mL 100 mL | 52285 | Enquire |
| LEVODOPA / CARBIDOPA TABLET ORAL 100 mg/25 mg | 52301 | Enquire |
| TRIENTINE HYDROCHLORIDE CAPSULE ORAL 250 mg | 52319 | Enquire |
| ANTI-D IMMUNOGLOBULIN INJECTION, SOLUTION INTRAMUSCULAR 300 ug/2mL | 52345 | Enquire |
| DIAZOXIDE TABLET ORAL 50 mg | 52351 | Enquire |
| NIVOLUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 10 mg/1mL 4 mL | 52363 | Enquire |
| PREDNISOLONE ACETATE SUSPENSION, DROPS OPHTHALMIC 1 % 5 mL | 52376 | Enquire |
| POTASSIUM CHLORIDE CONCENTRATED INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 2 meq/1mL 10 mL | 52379 | Enquire |
| UMECLIDINIUM (AS BROMIDE) / VILANTEROL (AS TRIFENATATE) POWDER RESPIRATORY 62.5 ug/25 ug/1{Puff} | 52429 | Enquire |
| UMECLIDINIUM (AS BROMIDE) / VILANTEROL (AS TRIFENATATE) POWDER, METERED RESPIRATORY 62.5 ug/25 ug/1{Puff} 30 {dose} | 52429 | Enquire |
| VITAMIN K1 (PHYTOMENADIONE) TABLET, CHEWABLE ORAL 10 mg | 52467 | Enquire |
| HYDRALAZINE HYDROCHLORIDE INJECTION, SOLUTION, CONCENTRATE PARENTERAL 20 mg 1 mL | 52478 | Enquire |
| PEGASPARGASE INJECTION, SOLUTION PARENTERAL 750 [iU]/1mL 5 mL | 52504 | Enquire |
| DAUNORUBICIN (AS HYDROCHLORIDE) INJECTION, SOLUTION PARENTERAL 2 mg/1mL 10 mL | 52506 | Enquire |
| ETHOSUXIMIDE SYRUP ORAL 250 mg/5mL 200 mL | 52620 | Enquire |
| DARATUMUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 400 MG | 52628 | Enquire |
| VINBLASTINE SULFATE INJECTION, SOLUTION PARENTERAL 1 mg/1mL 10 mL | 52631 | Enquire |
| OXANDROLONE TABLET ORAL 10 mg | 52688 | Enquire |
| REMDESIVIR INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg | 52689 | Enquire |
| REMDESIVIR INJECTION, SOLUTION PARENTERAL 5 mg/1mL 20 mL | 52707 | Enquire |
| BLINATUMOMAB INJECTION, POWDER, FOR SOLUTION PARENTERAL 38.5 ug | 52711 | Enquire |
| LIDOCAINE HYDROCHLORIDE GEL TOPICAL 2 % 25 g | 52766 | Enquire |
| PIRACETAM LIQUID ORAL 33.33 % 200 mL | 52769 | Enquire |
| SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 20 % 50 mL | 52793 | Enquire |
| NATAMYCIN SOLUTION, DROPS OPHTHALMIC 5 % 5 mL | 52905 | Enquire |
| LIPID INFUSION 20% (3) INJECTION, EMULSION INTRAVENOUS 80 mg/100 mg/20 mg/1mL 250 mL | 52913 | Enquire |
| CALCIUM FOLINATE INJECTION, POWDER PARENTERAL 200 mg | 52936 | Enquire |
| ETHOSUXIMIDE SYRUP ORAL 250 mg/5mL 100 mL | 52957 | Enquire |
| NUSINERSEN (AS SODIUM) INJECTION, SOLUTION PARENTERAL 2.4 mg/1mL 5 mL | 52998 | Enquire |
| PAPAVERINE HYDROCHLORIDE INJECTION PARENTERAL 20 mg/1mL 2 mL | 53026 | Enquire |
| PRALIDOXIME IODIDE INJECTION, SOLUTION PARENTERAL 25 mg/1 mL 20 mL | 53051 | Enquire |
| LIPID INFUSION 10% (2) INJECTION, SOLUTION INTRAVENOUS 100 mg/22 mg/12 mg/1mL 500 mL | 53067 | Enquire |
| GUSELKUMAB INJECTION, SOLUTION PARENTERAL 100 mg/1mL 1 mL | 53140 | Enquire |
| METHOXSALEN INJECTION PARENTERAL 20 ug/1mL 5 mL | 53217 | Enquire |
| AMINO ACID 10% PAEDIATRIC (1) INJECTION, SOLUTION INTRAVENOUS 8 mg/13 mg/8.51 mg/3.12 mg/3.75 mg/4.4 mg/2.01 mg/9 mg/7.5 mg/4.76 mg/9.3 mg/4.15 mg/0.7 mg/2.3 mg/1.6 mg/9.71 mg/7.67 mg/5.176 mg/2.26 mg/0.4 mg/1 mL/1mL 100 mL | 53310 | Enquire |
| DANTROLENE SODIUM INJECTION, POWDER PARENTERAL 120 mg | 53476 | Enquire |
A reference list for enquiries, not a statement of stock, registration or guaranteed availability. Names and codes are kept exactly as in the original working list; specifications, documentation and commercial terms are discussed per request.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.